The authors reply

New England Journal of Medicine

Volumn 370, Issue 25, 2014, Pages 2447-2448

  Kamar, Nassim ^a   Mallet, Vincent ^b   Izopet, Jacques ^c  

^a CHU RANGUEIL   (France)

^b INSTITUT COCHIN   (France)

^c CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; GLUCOCORTICOID; HEPATITIS E ANTIBODY; HEPATITIS VACCINE; MAMMALIAN TARGET OF RAPAMYCIN; MYCOPHENOLIC ACID; PRASTERONE; RIBAVIRIN; TACROLIMUS; ANTIVIRUS AGENT;

ANEMIA; BLOOD TRANSFUSION; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MONITORING; DRUG TOLERANCE; GENOTYPE; GUILLAIN BARRE SYNDROME; HEMOLYTIC ANEMIA; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; LETTER; MUSCLE ATROPHY; PRIORITY JOURNAL; TREATMENT RESPONSE; FEMALE; MALE; NOTE; ORGAN TRANSPLANTATION;

ANTIVIRAL AGENTS; FEMALE; HEPATITIS E; HUMANS; MALE; ORGAN TRANSPLANTATION; RIBAVIRIN;

EID: 84902592972     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1405191     Document Type: Letter

References (4)

1. Brochot E, Bodeau S, Nguyen-Khac E, Duverlie G. DHEA and progesterone have a protective effect on ribavirin-induced hemolysis. J Hepatol 2014;60:897-8.
2. Vanrenterghem Y, Ponticelli C, Morales JM, et al. Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 2003;3:835-45. (Pubitemid 36827905)
3. Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev 2014;27:116-38.
4. Abravanel F, Lhomme S, Chapuy-Regaud S, et al. Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve into chronic infections. J Infect Dis 2014 March 11 (Epub ahead of print).